Thalidomide for the treatment of leptomeningeal multiple myeloma

被引：21
作者：
Hattori, Y
Yabe, M
Okamoto, S
Morita, K
Tanigawara, Y
Ikeda, Y
机构：
[1] Keio Univ, Sch Med, Div Hematol, Dept Med,Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Hosp Pharm, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2006年 / 76卷 / 04期
关键词：
D O I：
10.1111/j.1600-0609.2005.00591.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：358 / 359
页数：2
相关论文
共 4 条
[1]   Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations [J].
Fassas, ABT ;
Muwalla, F ;
Berryman, T ;
Benramdane, R ;
Joseph, L ;
Anaissie, E ;
Sethi, R ;
Desikan, R ;
Siegel, D ;
Badros, A ;
Toor, A ;
Zangari, M ;
Morris, C ;
Angtuaco, E ;
Mathew, S ;
Wilson, C ;
Hough, A ;
Harik, S ;
Barlogie, B ;
Tricot, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (01) :103-108
[2]   Thalidomide for the treatment of refractory multiple myeloma: Association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome [J].
Kakimoto, T ;
Hattori, Y ;
Okamoto, S ;
Sato, N ;
Kamata, T ;
Yamaguchi, M ;
Morita, K ;
Yamada, T ;
Takayama, N ;
Uchida, H ;
Shimada, N ;
Tanigawara, Y ;
Ikeda, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (09) :1029-1036
[3]   Meningeal and cerebral involvement in multiple myeloma patients [J].
Patriarca, F ;
Zaja, F ;
Silvestri, F ;
Sperotto, A ;
Scalise, A ;
Gigli, G ;
Fanin, R .
ANNALS OF HEMATOLOGY, 2001, 80 (12) :758-762
[4]   Can thalidomide be effective to treat plasma cell leptomeningeal infiltration? [J].
Vicari, P ;
Ribas, C ;
Sampaio, M ;
Arantes, AM ;
Yamamoto, M ;
Reis, JB ;
Segreto, RA ;
Bordin, JO ;
Colleoni, GWB .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (03) :198-199
1